Ferric carboxymaltose for the treatment of iron-deficiency anemia
- 13 March 2012
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 13 (6) , 907-921
Abstract
Introduction : Anemic patients may benefit from the various intravenous iron replacement options available. Ferric carboxymaltose (FCM) is a new iron formulation (150 kDa) that can be given at high doses (20 mg/kg, up to 1000 mg) over a short period (≤ 15 min), without test dosing. Areas covered : This paper reviews studies dealing with the efficacy and safety of FCM for treating anemia in relatively large numbers of patients, in addition to analyzing the differences regarding clinical conditions, iron doses, follow-up, comparators, and hematologic response targets. Expert opinion : Overall, there is substantial evidence that FCM is effective in treating iron-deficiency anemia in many acute and chronic conditions, with a favorable benefit–risk profile. The efficacy of FCM for correcting anemia is similar to that of iron sucrose, and it is superior to oral iron or placebo in replenishing iron stores. Despite higher acquisition costs (as fewer administrations are needed), treatment with FCM (as well as with iron isomaltoside 1000 or ferumoxytol) seems to be cost-effective when compared to iron sucrose, and is more convenient for patients. There are, however, some aspects (such as hypophosphatemia) and important missing information (such as use in children and pregnant women) that need to be addressed for facilitating a widespread use of FCM.Keywords
This publication has 43 references indexed in Scilit:
- Disorders of iron metabolism. Part II: iron deficiency and iron overloadJournal of Clinical Pathology, 2010
- Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasisJournal of Clinical Pathology, 2010
- Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartumArchives of Gynecology and Obstetrics, 2010
- The Impact of Anemia on the Prognosis of Chronic Heart Failure: A Meta‐Analysis and Systemic ReviewCongestive Heart Failure, 2009
- Common Misconceptions in the Diagnosis and Management of Anemia in Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 2008
- Preoperative Hematocrit Levels and Postoperative Outcomes in Older Patients Undergoing Noncardiac SurgeryJAMA, 2007
- Anemia in chronic kidney disease: causes, diagnosis, treatment.Cleveland Clinic Journal of Medicine, 2006
- The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patientsEuropean Journal of Cancer, 2004
- Anemia and Blood Transfusion in Critically Ill PatientsJAMA, 2002
- Erythropoietin, iron, and erythropoiesisBlood, 2000